158 related articles for article (PubMed ID: 25762035)
1. False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis.
Gonzalez WO; Massera D; Travin MI
J Nucl Cardiol; 2015 Dec; 22(6):1323-5. PubMed ID: 25762035
[No Abstract] [Full Text] [Related]
2. Diagnosis of cardiac sarcoidosis through mismatched defects seen on N-13 NH3/F-18 FDG cardiac PET.
Chen S; Bokhari S
Clin Nucl Med; 2011 Dec; 36(12):1156-7. PubMed ID: 22064101
[No Abstract] [Full Text] [Related]
3. Early detection of cardiac sarcoidosis: comparison of 18F-FDG PET with 11C-choline PET.
Miwa S; Inui N; Suda T; Miyazaki H; Torizuka T; Chida K
Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):156-8. PubMed ID: 18496990
[No Abstract] [Full Text] [Related]
4. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
Brancato SC; Arrighi JA
J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
[No Abstract] [Full Text] [Related]
5. 18F-FDG PET scan as follow-up tool for sarcoidosis with symptomatic cardiac conduction disturbances requiring a pacemaker.
Györik S; Ceriani L; Menafoglio A; Gallino A; Wyttenbach R
Thorax; 2007 Jun; 62(6):560. PubMed ID: 17536038
[No Abstract] [Full Text] [Related]
6. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
[TBL] [Abstract][Full Text] [Related]
7. Cardiac FDG/PET imaging mimicking sarcoidosis.
Lai JKC; Teo E; Lichtenstein M; Toh HB; Sivaratnam D
J Nucl Cardiol; 2019 Jun; 26(3):1025-1027. PubMed ID: 30627883
[No Abstract] [Full Text] [Related]
8. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
9. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
[TBL] [Abstract][Full Text] [Related]
10. Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
Ostwani W; Hanna C; Brice AE; Wymer DC
J Nucl Med Technol; 2020 Dec; 48(4):378-380. PubMed ID: 32518122
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide Assessment of Sarcoidosis.
Divakaran S
Cardiol Clin; 2023 May; 41(2):207-215. PubMed ID: 37003678
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac sarcoidosis detected by FDG-PET].
Goto K; Okamoto E; Morita M; Sasamoto T; Endo M; Umezawa K; Suguta M; Kaneko Y; Nakano A; Arai M; Hasegawa A; Kurabayashi M
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1396-8. PubMed ID: 16097596
[No Abstract] [Full Text] [Related]
13. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
14. Atrial Fibrillation and Cardiac Sarcoidosis: The Aperture Widens Through the Lens of FDG-PET Imaging.
Sheikh FH; Gilotra NA
JACC Cardiovasc Imaging; 2022 Sep; 15(9):1632-1634. PubMed ID: 36075624
[No Abstract] [Full Text] [Related]
15. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
16. Cardiac sarcoidosis: a challenge to measure disease activity.
Keijsers RG; Verzijlbergen FJ; Rensing BJ; Grutters JC
J Nucl Cardiol; 2008; 15(4):595-8. PubMed ID: 18674727
[No Abstract] [Full Text] [Related]
17. FDG PET imaging in suspected cardiac sarcoidosis: diagnosis vs. prognosis.
Divakaran S; Blankstein R
J Nucl Cardiol; 2022 Oct; 29(5):2471-2473. PubMed ID: 34608605
[No Abstract] [Full Text] [Related]
18. The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis.
Mc Ardle BA; Leung E; Ohira H; Cocker MS; deKemp RA; DaSilva J; Birnie D; Beanlands RS; Nery PB
J Nucl Cardiol; 2013 Apr; 20(2):297-306. PubMed ID: 23288545
[TBL] [Abstract][Full Text] [Related]
19. Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis.
Alvi RM; Young BD; Shahab Z; Pan H; Winkler J; Herzog E; Miller EJ
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1284-1287. PubMed ID: 30846271
[No Abstract] [Full Text] [Related]
20. Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?
Brunken RC
J Nucl Cardiol; 2022 Feb; 29(1):97-100. PubMed ID: 32676908
[No Abstract] [Full Text] [Related]
[Next] [New Search]
